National Healthcare Properties Inc is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing operating properties (SHOP) and outpatient medical facilities (OMF), located in the United States... Show more
The Stochastic Oscillator for NHPBP moved out of overbought territory on August 15, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 54 similar instances where the indicator exited the overbought zone. In of the 54 cases the stock moved lower. This puts the odds of a downward move at .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NHPBP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
NHPBP broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Moving Average Convergence Divergence (MACD) for NHPBP just turned positive on August 11, 2025. Looking at past instances where NHPBP's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .
The 50-day moving average for NHPBP moved above the 200-day moving average on July 14, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NHPBP advanced for three days, in of 184 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 143 cases where NHPBP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NHPBP's P/B Ratio (0.000) is slightly lower than the industry average of (1.938). NHPBP has a moderately low P/E Ratio (0.000) as compared to the industry average of (43.091). NHPBP's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.197). NHPBP has a moderately high Dividend Yield (0.105) as compared to the industry average of (0.064). NHPBP's P/S Ratio (0.000) is slightly lower than the industry average of (6.632).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NHPBP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NHPBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
A.I.dvisor indicates that over the last year, NHPBP has been loosely correlated with NHPAP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NHPBP jumps, then NHPAP could also see price increases.
Ticker / NAME | Correlation To NHPBP | 1D Price Change % | ||
---|---|---|---|---|
NHPBP | 100% | +0.06% | ||
NHPAP - NHPBP | 35% Loosely correlated | +1.03% | ||
ALEX - NHPBP | 34% Loosely correlated | +0.27% | ||
IVT - NHPBP | 33% Loosely correlated | +0.07% | ||
OUT - NHPBP | 33% Loosely correlated | +1.90% | ||
FR - NHPBP | 32% Poorly correlated | +0.78% | ||
More |
Ticker / NAME | Correlation To NHPBP | 1D Price Change % |
---|---|---|
NHPBP | 100% | +0.06% |
Managed Health Care industry (28 stocks) | 23% Poorly correlated | +0.17% |
Health Services industry (441 stocks) | 14% Poorly correlated | -0.03% |